Basic science for the clinician 35 -: CD1, invariant NKT (iNKT) cells, and γδ T-cells

被引:8
|
作者
Sigal, LH
机构
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Rheumatol & Connect Tissue Res, Dept Med, New Brunswick, NJ USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, New Brunswick, NJ 08903 USA
关键词
CD1; gamma delta T-cells; invariant NKT cell; phosphoantigens; lipid antigens;
D O I
10.1097/01.rhu.0000191149.21528.f7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As noted in previous articles in this series, the very heterogeneous MHC class I and II molecules present peptide antigens to T-cells. However, there is another family of less heterogeneous MHC-related molecules. CD11 molecules present lipid antigens, oftentimes to 2 other distinct families of T-cells: gamma delta T-cells (named because they bear a T-cell antigen receptor consisting of a gamma chain and a delta chain rather than the a chain/beta chain heterodimer on most T-cells) and iNKT cells (T-cells that bear markers previously defined on natural killer cells). CD1 molecules and the gamma delta T-cells and iNKT cells to which they present antigens have fundamental responsibilities for immune surveillance over intracellular pathogens and serve other roles that place them at the boundary between innate and acquired immunity. The gamma delta T-cell has been implicated in the pathogenesis of many diseases, rheumatologic and otherwise, suggesting that better understanding of these cells, and of CD1 molecules, may help us explain the immunopathogenesis of some inflammatory diseases and how to craft more targeted therapies in many fields of medicine.
引用
收藏
页码:336 / 339
页数:4
相关论文
共 50 条
  • [1] CD1 RECOGNITION BY CYTOTOXIC T-CELLS
    BLEICHER, PA
    VIBBARD, C
    CLINICAL RESEARCH, 1991, 39 (02): : A498 - A498
  • [2] CD1 RECOGNITION BY CYTOTOXIC T-CELLS
    BLEICHER, PA
    VIBBARD, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (04) : 602 - 602
  • [3] Basic science for the clinician 32 - T-cells with regulatory function
    Sigal, LH
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (05) : 286 - 289
  • [4] Antigen Presentation by CD1: Lipids, T Cells, and NKT Celts in Microbial Immunity
    Cohen, Nadia R.
    Garg, Salil
    Brenner, Michael B.
    ADVANCES IN IMMUNOLOGY, VOL 102, 2009, 102 : 1 - 94
  • [5] Role of CD1 and MR1-restricted T-cells in diabetes
    Lehuen, A.
    IMMUNOLOGY, 2014, 143 : 15 - 15
  • [6] Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells
    Griseri, T
    Beaudoin, L
    Novak, J
    Mars, LT
    Lepault, F
    Liblau, R
    Lehuen, AS
    JOURNAL OF IMMUNOLOGY, 2005, 175 (04): : 2091 - 2101
  • [7] TACI is required for maintaining the numbers and functions of invariant NKT (iNKT) cells
    Quah, P. S.
    Fairfax, K.
    Andrews, D.
    Mackay, F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 183 - 183
  • [8] Autoimmunity to glycolipids in neuropathy; Role of T-cells and of CD1 dependent antigen presentation
    Latov, N.
    Kusunoki, S.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 57 - 57
  • [9] Autoimmunity to glycolipids in neuropathy; Role of T-cells and of CD1 dependent antigen presentation
    Latov, N.
    CURRENT TOPICS IN NEUROIMMUNOLOGY, 2006, : 235 - 239
  • [10] THE INTERACTION BETWEEN REGULATORY T CELLS AND NKT CELLS IN THE LIVER: A CD1 D BRIDGE LINKS INNATE AND ADAPTIVE IMMUNITY
    Hua, Jing
    Ma, Xiong
    Li, Zhiping
    HEPATOLOGY, 2009, 50 (04) : 344A - 344A